N. Örmeci Et Al. , "Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months," Hepato-Gastroenterology , vol.58, no.110-111, pp.1648-1653, 2011
Örmeci, N. Et Al. 2011. Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months. Hepato-Gastroenterology , vol.58, no.110-111 , 1648-1653.
Örmeci, N., Bölükbaş, F., Erden, E., Çoban, Ş., Ekiz, F., Erdem, H., ... Palabiyikoǧlu, M.(2011). Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months. Hepato-Gastroenterology , vol.58, no.110-111, 1648-1653.
Örmeci, Necati Et Al. "Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months," Hepato-Gastroenterology , vol.58, no.110-111, 1648-1653, 2011
Örmeci, Necati Et Al. "Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months." Hepato-Gastroenterology , vol.58, no.110-111, pp.1648-1653, 2011
Örmeci, N. Et Al. (2011) . "Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months." Hepato-Gastroenterology , vol.58, no.110-111, pp.1648-1653.
@article{article, author={Necati Örmeci Et Al. }, title={Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months}, journal={Hepato-Gastroenterology}, year=2011, pages={1648-1653} }